BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22829690)

  • 21. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
    Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma.
    Ding Q; Jin T; Wang Z; Chen Y
    J Leukoc Biol; 2007 Jun; 81(6):1568-76. PubMed ID: 17369494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis.
    Mueller RB; Skapenko A; Wendler J; Schuch F; Kalden JR; Schulze-Koops H
    Rheumatology (Oxford); 2007 Jun; 46(6):931-3. PubMed ID: 17384177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y; Ping J; Xu LM
    Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation.
    van Roon J; Wijngaarden S; Lafeber FP; Damen C; van de Winkel J; Bijlsma JW
    J Rheumatol; 2003 Apr; 30(4):648-51. PubMed ID: 12672180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages.
    Mimche PN; Thompson E; Taramelli D; Vivas L
    J Antimicrob Chemother; 2012 Aug; 67(8):1895-904. PubMed ID: 22511637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage.
    Billiet L; Furman C; Larigauderie G; Copin C; Page S; Fruchart JC; Brand K; Rouis M
    J Cell Physiol; 2008 Jan; 214(1):183-91. PubMed ID: 17579352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High density lipoprotein suppresses lipoprotein associated phospholipase A2 in human monocytes-derived macrophages through peroxisome proliferator-activated receptor-γ pathway.
    Han GP; Ren JY; Qin L; Song JX; Wang L; Chen H
    Chin Med J (Engl); 2012 Dec; 125(24):4474-80. PubMed ID: 23253723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes.
    Boyer JF; Balard P; Authier H; Faucon B; Bernad J; Mazières B; Davignon JL; Cantagrel A; Pipy B; Constantin A
    Arthritis Res Ther; 2007; 9(2):R22. PubMed ID: 17335569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis.
    Huang J; Xie B; Li Q; Xie X; Zhu S; Wang M; Peng W; Gu J
    Eur J Pharmacol; 2013 Jan; 698(1-3):429-34. PubMed ID: 23146660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
    Karonitsch T; von Dalwigk K; Steiner CW; Blüml S; Steiner G; Kiener HP; Smolen JS; Aringer M
    Arthritis Rheum; 2012 Feb; 64(2):400-8. PubMed ID: 21953607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
    Kim HY; Kim JR; Kim HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.